glp-1 news today oct 2 2025 Alarming rise in weight loss drug overdoses GLP-1s in 2026: What Brokers

During fermentation, sulfur-containing compounds break down into hydrogen sulfide gas

Reduced norepinephrine turnover in interscapular brown adipose tissue of obese rats after ovariectomy

Log meals by photo, label, barcode (OpenFoodFacts), or voice with AI Meal Snap

RNA sequencing library was prepared via the rRNA depletion method for the first experiment (ethanol study)

No new safety signals were observed ( The second SGLT2 inhibitor, empagliflozin, was tested in a randomized trial assessing its pharmacokinetic and pharmacodynamic profile and identifying the appropriate doses in young people with T2D aged 10 to 17 years

In August 2024, we surveyed 23andMe research participants about their GLP1 medication usage, focusing on those taking weight loss medication